BR100 Increased By (0.01%)
BR30 Increased By (0.53%)
KSE100 Increased By (0.28%)
KSE30 Increased By (0.29%)
AGHA 6.35 Increased By ▲ 0.03 (0.47%)
BECO 4.39 Increased By ▲ 0.12 (2.81%)
BML 62.50 Increased By ▲ 0.05 (0.08%)
BOP 31.47 Increased By ▲ 0.24 (0.77%)
CNERGY 11.70 Increased By ▲ 0.11 (0.95%)
CSIL 5.92 Increased By ▲ 0.20 (3.5%)
FCCL 61.60 Increased By ▲ 0.06 (0.1%)
FFL 14.79 Decreased By ▼ -0.23 (-1.53%)
FNEL 1.23 No Change ▼ 0.00 (0%)
KEL 6.33 Increased By ▲ 0.07 (1.12%)
KOSM 5.90 Increased By ▲ 0.34 (6.12%)
LOTCHEM 24.79 Increased By ▲ 0.11 (0.45%)
MLCF 103.93 Decreased By ▼ -0.15 (-0.14%)
NBP 173.05 Decreased By ▼ -2.23 (-1.27%)
NCPL 51.85 Decreased By ▼ -0.92 (-1.74%)
NPL 54.19 Increased By ▲ 0.07 (0.13%)
OGDC 315.50 Increased By ▲ 2.11 (0.67%)
PACE 9.26 Increased By ▲ 0.06 (0.65%)
PAEL 35.51 Decreased By ▼ -0.29 (-0.81%)
PIBTL 13.65 Increased By ▲ 0.18 (1.34%)
PPL 226.60 Increased By ▲ 4.79 (2.16%)
PRL 80.30 Increased By ▲ 1.22 (1.54%)
PTC 46.89 Increased By ▲ 0.04 (0.09%)
SSGC 23.90 Increased By ▲ 0.03 (0.13%)
TBL 9.30 Decreased By ▼ -0.01 (-0.11%)
TELE 7.65 Increased By ▲ 0.26 (3.52%)
TPL 24.51 Decreased By ▼ -0.60 (-2.39%)
TPLP 13.04 Increased By ▲ 0.53 (4.24%)
TREET 26.05 Decreased By ▼ -0.20 (-0.76%)
TRG 53.38 Decreased By ▼ -0.06 (-0.11%)
By

SHANGHAI: Chinese stocks rose on Thursday, led by artificial intelligence (AI) shares after US chipmaker Nvidia’s better-than-expected revenue forecast. Hong Kong shares were roughly flat.

China stocks extend rally on market rescue measures

  • China’s blue-chip CSI 300 Index was up 0.3% by the lunch break, while the Shanghai Composite Index gained 0.5%. ** Hong Kong benchmark Hang Seng Index edged up 0.2%.

  • China’s AI stocks surged nearly 4% before entering the midday break up around 2.4%, after Nvidia on Wednesday forecast a roughly threefold surge in quarterly revenue, beating expectations.

  • Cambricon Technologies, one of China’s top AI-related chipmakers, jumped more than 10%.

  • Coal and energy shares also rose, with PetroChina up 3%.

  • Morgan Stanley equity strategists said in a note that the state-owned enterprises reform theme recently gained investors’ attention as top-down policy focus seems to have returned.

  • China Traditional Chinese Medicine Holdings surged more than 20% after a consortium led by state-owned pharmaceutical giant Sinopharm has revived a take-private bid for the company.

  • Despite stock market performance improving on a raft of market rescue measures, investor sentiment can still be fragile without a material pickup in economic activities.

  • “Offshore investors in general remain cautious. They believe the recent rebound is mainly driven by short-covering and bearishness ahead of the Lunar New Year,” said analysts at UBS, adding that the property downturn and deflation remain major concerns.

  • Meanwhile, Chinese hedge fund managers are scrambling to soothe investors after a rout in small-value stocks, even as regulators step up scrutiny of major market players’ activities as they try to revive the country’s ailing stock markets.

Comments

Comments are closed for this article.